Intravascular Imaging-Guided Percutaneous Coronary Intervention Before and After Standardized Optimization Protocols

经皮冠状动脉介入治疗 医学 血管内超声 放射科 心脏病学 重症监护医学 心肌梗塞
作者
Woochan Kwon,David Hong,Ki Hong Choi,Seung Hun Lee,Doosup Shin,Jong‐Young Lee,Seung‐Jae Lee,Sang Yeub Lee,Sang Min Kim,Kyeong Ho Yun,Jae Young Cho,Chan Joon Kim,Hyo–Suk Ahn,Chang Wook Nam,Hyuck–Jun Yoon,Yong Hwan Park,Wang Soo Lee,Taek Kyu Park,Jeong Hoon Yang,Seung‐Hyuk Choi,Hyeon‐Cheol Gwon,Young Bin Song,Joo Yong Hahn,Joo Myung Lee
出处
期刊:Jacc-cardiovascular Interventions [Elsevier]
卷期号:17 (2): 292-303 被引量:1
标识
DOI:10.1016/j.jcin.2023.10.062
摘要

Although benefits of intravascular imaging (IVI) in percutaneous coronary intervention (PCI) have been observed in previous studies, it is not known whether changes in contemporary practice, especially with application of standardized optimization protocols, have improved clinical outcomes. The authors sought to investigate whether clinical outcomes of IVI-guided PCI are different before and after the application of standardized optimization protocols in using IVI. 2,972 patients from an institutional registry (2008-2015, before application of standardized optimization protocols, the past group) and 1,639 patients from a recently published trial (2018-2021 after application of standardized optimization protocols, the present group) were divided into 2 groups according to use of IVI. The primary outcome was 3-year target vessel failure (TVF), a composite of cardiac death, target vessel myocardial infarction, or target vessel revascularization. Significant reduction of TVF was observed in the IVI-guided PCI group compared with the angiography-guided PCI group (10.0% vs 6.7%; HR: 0.77; 95% CI: 0.61-0.97; P = 0.027), mainly driven by reduced cardiac death or myocardial infarction in both past and present IVI-guided PCI groups. When comparing past IVI and present IVI groups, TVF was significantly lower in the present IVI group (8.5% vs 5.1%; HR: 0.63; 95% CI: 0.42-0.94; P = 0.025), with the difference being driven by reduced target vessel revascularization in the present IVI group. Consistent results were observed in inverse-probability-weighting adjusted analysis. IVI-guided PCI improved clinical outcomes more than angiography-guided PCI. In addition, application of standardized optimization protocols when using IVI further improved clinical outcomes after PCI. (Intravascular Imaging- Versus Angiography-Guided Percutaneous Coronary Intervention For Complex Coronary Artery Disease [RENOVATE-COMPLEX-PCI]; NCT03381872; and the institutional cardiovascular catheterization database of Samsung Medical Center: Long-Term Outcomes and Prognostic Factors in Patient Undergoing CABG or PCI; NCT03870815)

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zhizhi发布了新的文献求助10
刚刚
开心仙人掌完成签到,获得积分10
1秒前
1秒前
2秒前
学术小白完成签到,获得积分10
3秒前
4秒前
4秒前
柚子发布了新的文献求助10
5秒前
5秒前
5秒前
6秒前
烟花应助琳琳采纳,获得30
6秒前
刻舟求应助露桥闻笛采纳,获得10
6秒前
7秒前
飞儿完成签到,获得积分10
7秒前
7秒前
8秒前
imp发布了新的文献求助10
9秒前
9秒前
犹豫三问发布了新的文献求助10
9秒前
黄先生发布了新的文献求助10
10秒前
111发布了新的文献求助10
11秒前
余如龙发布了新的文献求助10
11秒前
14秒前
量子星尘发布了新的文献求助10
14秒前
imp完成签到,获得积分10
15秒前
趣多多发布了新的文献求助10
15秒前
17秒前
17秒前
想吃见手青完成签到 ,获得积分10
19秒前
19秒前
坦率灵槐应助科研通管家采纳,获得10
20秒前
浮游应助科研通管家采纳,获得10
20秒前
共享精神应助科研通管家采纳,获得10
20秒前
李爱国应助科研通管家采纳,获得10
20秒前
ccm应助科研通管家采纳,获得10
20秒前
坦率灵槐应助科研通管家采纳,获得10
20秒前
汉堡包应助科研通管家采纳,获得20
20秒前
渡花应助科研通管家采纳,获得10
20秒前
浮游应助科研通管家采纳,获得10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Reproduction Third Edition 3000
Comprehensive Methanol Science Production, Applications, and Emerging Technologies 2000
化妆品原料学 1000
Psychology of Self-Regulation 800
1st Edition Sports Rehabilitation and Training Multidisciplinary Perspectives By Richard Moss, Adam Gledhill 600
Red Book: 2024–2027 Report of the Committee on Infectious Diseases 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5642531
求助须知:如何正确求助?哪些是违规求助? 4759094
关于积分的说明 15017959
捐赠科研通 4801089
什么是DOI,文献DOI怎么找? 2566399
邀请新用户注册赠送积分活动 1524484
关于科研通互助平台的介绍 1484011